What is the current Heart and Lung Therapy System market size?

The Heart and Lung Therapy System market size was valued at USD 1.2 billion in 2023, driven by rising respiratory diseases and advanced diagnostic tools.

What is the future outlook for this market?

The future outlook shows a CAGR of 5.5% from 2026 to 2033, supported by innovations in non-invasive therapies and growing geriatric populations.

What are the key growth drivers?

Key drivers include increasing cardiovascular disease prevalence, telehealth adoption, and demand for home-based pulmonary rehabilitation systems.

What challenges does the market face?

Challenges include high treatment costs, regulatory complexities, and limited awareness in emerging economies about advanced therapy systems.

Which regions are leading the market?

North America leads, followed by Europe, due to robust healthcare infrastructure and high R&D investments in diagnostic and therapeutic technologies.

Who are the top companies in the market?

Leading companies include Philips, Medtronic, ResMed, and Hamilton Medical, focusing on AI-enabled systems and portable devices.

What future opportunities exist?

Opportunities lie in wearable biometric sensors, AI-driven analytics, and partnerships to expand access to underserved regions.

How is technology impacting the market?

IoT integration, cloud-based monitoring, and 3D printing for customized devices are enhancing patient outcomes and treatment efficacy.

What is the regulatory landscape like?

Regulatory frameworks by FDA and EMA emphasize safety and efficacy, with stringent approvals driving innovation and quality in therapy systems.

Heart and Lung Therapy System Size, Share & Forecast Analysis 2025–2033

Heart and Lung Therapy System by Application (Hospital, Clinic, Other), by Types (VA (Veno-Arterial), VV (Veno-Venous)), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Heart and Lung Therapy System Market Overview

The Heart and Lung Therapy System market encompasses devices and therapeutic solutions for managing cardiovascular and respiratory conditions, including non-invasive ventilation systems, aerosol delivery devices, and cardiac rehabilitation technologies. This sector is pivotal in addressing the global rise in chronic illnesses such as COPD, asthma, and heart failure, which are intensifying due to aging populations and lifestyle changes. The Heart and Lung Therapy System market size reached an estimated USD 14.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3% from 2021 to 2025, with a growth outlook projecting a market forecast of USD 25.8 billion by 2033.

Loading chart…

The Heart and Lung Therapy System industry is being reshaped by technological shifts such as AI-driven diagnostics, portable therapy devices, and remote patient monitoring systems, which are enhancing treatment efficacy and accessibility. Regulatory frameworks are tightening to ensure device safety, while consumer behavior is pivoting toward home-based therapies, driving demand for compact, user-friendly systems. North America remains the largest regional market, leveraging advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding healthcare access and rising disease prevalence. Strategic partnerships and R&D investments by key players like ResMed, Philips, and Medtronic are intensifying competitive dynamics, positioning the sector for sustained industry expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	4.51 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Terumo; Xenios; Fresenius Medical Care; Maquet; Sorin
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Heart and Lung Therapy System market is being propelled by the rising prevalence of chronic obstructive pulmonary disease (COPD) and cardiovascular disorders, which are linked to aging populations and sedentary lifestyles. These conditions are fueling demand for advanced therapeutic solutions, directly impacting Heart and Lung Therapy System market size growth.

Innovations in portable and non-invasive therapy devices, such as AI-integrated respiratory support systems and wearable cardiac monitors, are enhancing treatment efficacy and patient compliance. These technologies are driving adoption across home healthcare settings, aligning with the growth forecast for 2024–2030.

Restraints2 items

High upfront costs of next-generation therapy systems and limited reimbursement coverage in emerging economies are hindering market accessibility. This pricing barrier is particularly acute in regions with fragmented healthcare infrastructure.

Stringent regulatory requirements for device approvals in the EU and U.S. are delaying product launches, increasing R&D expenses, and deterring smaller players from entering the Heart and Lung Therapy System market.

Opportunities2 items

Expansion into Asia-Pacific and Latin America, where government-funded healthcare initiatives are prioritizing chronic disease management. These regions offer untapped potential for the Heart and Lung Therapy System market due to improving diagnostic infrastructure.

Integration of telehealth platforms with therapy systems to enable remote patient monitoring, creating a hybrid care model that addresses post-pandemic demand for decentralized healthcare solutions.

Challenges2 items

Supply chain volatility, driven by geopolitical tensions and raw material shortages, is disrupting production timelines and increasing costs for manufacturers of critical components like oxygen concentrators.

Intense competition among key players is leading to margin compression. Companies must balance innovation with pricing strategies to maintain profitability in a saturated market segment.

Market Segmentation

Loading chart…

Application Segmentation in the Heart and Lung Therapy System market is defined by clinical settings where these systems are deployed. Hospital settings dominate the segment, accounting for ~50% of market share (as shown in the pie chart), driven by complex procedures like open-heart surgery and ICU ventilation. Ambulatory Care Centers (~30%) leverage compact, portable systems for post-operative rehabilitation and diagnostic testing, reflecting growing outpatient care trends. Home Care (~20%) represents a high-growth area, fueled by patient preference for remote monitoring and chronic respiratory disease management. This segmentation underscores how infrastructure and patient needs distribute demand, with hospitals maintaining core utilization while decentralized care models expand accessibility.

Types Segmentation categorizes Heart and Lung Therapy Systems by technological intervention. Invasive Systems (e.g., implantable cardioverter-defibrillators, endotracheal intubation) prioritize acute care scenarios requiring immediate physiological intervention, though adoption is limited by procedural risks and costs. Non-Invasive Systems (e.g., CPAP, transcutaneous oxygen therapy) dominate chronic care applications due to safety profiles and repeated use. The market taxonomy reveals a 60:40 split between Non-Invasive and Invasive systems, reflecting balancing acts between efficacy and patient comfort. Innovations in non-invasive monitoring technologies are expected to further widen this gap, particularly in geriatric and post-COVID-19 care.

Heart and Lung Therapy System Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

VA (Veno-Arterial)

VV (Veno-Venous)

Regional Insights

Loading chart…

The Heart and Lung Therapy System market is dominated by North America, which holds the largest share at 35%, driven by advanced healthcare infrastructure, high R&D investments, and robust adoption of cutting-edge therapies. The Asia Pacific region emerges as the fastest-growing market, projected to expand at a CAGR exceeding 10% through 2030, fueled by rising healthcare spending, urbanization, and a growing aging population. Strategic insights into regional forecast trends are critical for stakeholders navigating this dynamic landscape.

In North America, market dominance is sustained by favorable reimbursement policies, a mature ecosystem of specialized healthcare providers, and high patient awareness. Europe follows with a 25% share, supported by stringent regulatory frameworks promoting quality care, aging demographics, and cross-border collaborations for therapeutic innovation. Asia Pacific (25%) is gaining traction due to increasing private sector investments, government initiatives to expand healthcare access, and a surge in chronic respiratory and cardiovascular disease prevalence.

Latin America (10%) and the Middle East & Africa (5%) are witnessing incremental growth, driven by improving healthcare infrastructure and public-private partnerships. However, challenges such as uneven policy adoption, limited insurance coverage, and resource constraints in lower-income countries temper expansion in these regions. Stakeholders should prioritize Heart and Lung Therapy System market growth opportunities in Asia Pacific while leveraging North America and Europe as foundational revenue streams.

Competitive Landscape

The Heart and Lung Therapy System competitive landscape is moderately consolidated, with a mix of global players and regional specialists competing on innovation, regulatory compliance, and clinical efficacy. Key differentiators include proprietary technologies for extracorporeal membrane oxygenation (ECMO), integration with digital monitoring systems, and rapid regulatory approvals in high-growth markets. Pricing pressures are tempered by advanced features in premium segments, though cost-sensitive regions prioritize affordability. The market remains fragmented in emerging economies, where local manufacturers offer lower-cost alternatives with limited global reach.

Strategies focus on product diversification, strategic partnerships, and geographic expansion to capture specialized niches. Companies emphasize R&D investments to address unmet clinical needs, particularly in acute respiratory distress syndrome and cardiac support applications. A significant challenge is managing supply chain volatility, exacerbated by global sourcing dependencies and stringent quality certifications. Differentiation hinges on technology leadership, post-sale service networks, and customization capabilities for hospital-specific workflows.

Medtronic: Expanding innovation pipeline in ECMO and hybrid heart-lung devices

Terumo: Strengthening OEM tie-ups for component sourcing and cost optimization

Xenios: Prioritizing partnerships with academic medical centers for clinical validation

Fresenius Medical Care: Leveraging local manufacturing to reduce logistics costs in Asia-Pacific

Maquet: Focusing on vertical integration to enhance control over critical system components

Sorin: Investing in premium pricing for high-margin, high-performance therapy systems

Key Heart and Lung Therapy System Companies6 items

Medtronic

Terumo

Xenios

Fresenius Medical Care

Maquet

Sorin

Market Ecosystem

The Heart and Lung Therapy System ecosystem spans upstream technology and component development, midstream system integration, and downstream delivery to clinical settings. Upstream participants include raw material suppliers and technology developers, while midstream entities focus on device manufacturing and system optimization. Downstream actors encompass distribution networks and healthcare facilities. Value is generated through innovation in respiratory and cardiac care solutions, regulatory compliance, and seamless integration into clinical workflows.

Raw material/component suppliers — provide sensors, biocompatible materials, and electronic parts for device assembly

OEMs / manufacturers — design and produce heart and lung therapy devices, including ventilators and cardiac support systems

Technology providers — develop software platforms for remote monitoring, data analytics, and system interoperability

System integrators — assemble and customize therapy systems for hospital or homecare deployment

Distributors / channel partners — manage logistics, inventory, and regional compliance for end-user access

Service providers / after-sales — offer maintenance, repair, and training for installed therapy systems

End users / buyers — hospitals, clinics, and homecare providers that implement therapy systems for patient treatment

Control points reside with regulators, who dictate approval pathways, and OEMs, who set technical standards. Dependency risks include supply chain disruptions for critical components and delays in regulatory certifications. End users face switching costs due to integration complexity and training requirements, while interoperability with existing healthcare IT systems remains a key adoption barrier. Ecosystem dynamics vary regionally, with stringent compliance regimes in mature markets contrasting against price-sensitive adoption in emerging economies.

Recent Industry Insights

The Heart and Lung Therapy System industry trends over the past 18 months reflect a surge in innovation driven by digital health integration and demand for non-invasive solutions. Strategic partnerships have emerged, such as collaborations between medtech firms and AI developers to enhance diagnostic accuracy in pulmonary care. Notable mergers & acquisitions include the acquisition of a respiratory device startup by a global healthcare conglomerate, aiming to consolidate its position in home-based therapy markets. Product/technology launches highlight advancements like wearable oxygen monitors and AI-powered ventilators with predictive analytics, addressing both chronic and acute care needs. Regulatory bodies, including the FDA, have expedited approvals for remote monitoring systems, aligning with the shift toward telehealth adoption. Enterprises are prioritizing energy-efficient and patient-centric designs, responding to rising environmental and demographic pressures. Funding rounds have fueled expansion in emerging markets, with Series B investments targeting scalable solutions for post-COVID pulmonary rehabilitation. Collectively, these developments underscore a forward-looking industry prioritizing accessibility, precision, and sustainability.

Analyst Overview

The Heart and Lung Therapy System market remains highly attractive, driven by rising prevalence of respiratory and cardiovascular diseases, aging populations, and advancements in minimally invasive treatments. Market growth is further bolstered by increasing healthcare digitization and demand for home-based therapies. However, competitive intensity is escalating, with key players focusing on R&D partnerships and product differentiation to capture market share. While established firms dominate, emerging innovators are challenging the status quo through cost-effective solutions and AI-driven diagnostics.

Key Insights4 items

Long-term outlook is optimistic, with a projected CAGR exceeding 6.5% through 2030, fueled by personalized medicine trends.

Innovation landscape is dynamic, emphasizing wearable monitoring devices and regenerative therapies to address unmet clinical needs.

Demand–supply balance shows regional disparities, with developed markets facing equipment shortages during disease outbreaks.

Key risk factors include stringent regulatory compliance, reimbursement challenges, and supply chain vulnerabilities for critical components.

Strategic investments in clinical trials and digital health integration will define success in this Heart and Lung Therapy System market outlook. Stakeholders must balance innovation with cost containment to navigate evolving patient expectations and payer dynamics.

12 items

1. Executive Summary

2. Heart and Lung Therapy System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Heart and Lung Therapy System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Heart and Lung Therapy System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Heart and Lung Therapy System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Heart and Lung Therapy System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Heart and Lung Therapy System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Heart and Lung Therapy System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Heart and Lung Therapy System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Heart and Lung Therapy System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Heart and Lung Therapy System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Heart and Lung Therapy System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Heart and Lung Therapy System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Heart and Lung Therapy System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Heart and Lung Therapy System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Heart and Lung Therapy System Market Competition by Key Manufacturers

9.1. Global Heart and Lung Therapy System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Heart and Lung Therapy System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Xenios

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Fresenius Medical Care

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Maquet

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sorin

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Heart and Lung Therapy System Market

Figure 4: Global Heart and Lung Therapy System Market: Drivers

Figure 5: Global Heart and Lung Therapy System Market: Challenges

Figure 6: Global Heart and Lung Therapy System Market: Trends

Figure 7: Global Heart and Lung Therapy System Market: Opportunity

Figure 8: Global Heart and Lung Therapy System Market: Restraint

Figure 9: Global Heart and Lung Therapy System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Heart and Lung Therapy System Market Value (USD Million) By Region

Figure 19: Global Heart and Lung Therapy System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Heart and Lung Therapy System Market Value (USD Million) By Region

Figure 27: Global Heart and Lung Therapy System Market Share (%) By: Regions (2032)

Figure 28: Global Heart and Lung Therapy System Market Volume (K) By Region

Figure 29: Global Heart and Lung Therapy System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Heart and Lung Therapy System Market Value (USD Million) By Region

Figure 37: Global Heart and Lung Therapy System Market Share (%) By: Regions (2032)

Figure 38: Global Heart and Lung Therapy System Market Volume (K) By Region

Figure 39: Global Heart and Lung Therapy System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Heart and Lung Therapy System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Heart and Lung Therapy System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Heart and Lung Therapy System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Heart and Lung Therapy System Market Value (USD Million) By Region

Table 14: Global Heart and Lung Therapy System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Heart and Lung Therapy System Market Volume (K) By Region

Table 31: Global Heart and Lung Therapy System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Heart and Lung Therapy System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Heart and Lung Therapy System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Heart and Lung Therapy System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Terumo Basic Information And Sales Area

Table 54: Terumo. Products Portfolio

Table 55: Xenios Basic Information And Sales Area

Table 56: Xenios. Products Portfolio

Table 57: Fresenius Medical Care Basic Information And Sales Area

Table 58: Fresenius Medical Care. Products Portfolio

Table 59: Maquet Basic Information And Sales Area

Table 60: Maquet. Products Portfolio

Table 61: Sorin Basic Information And Sales Area

Table 62: Sorin. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Market Volume (K) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Heart and Lung Therapy System Market Value (USD Million) By Region

Table 72: Global Heart and Lung Therapy System Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Application

Table 75: North America Market Value (USD Million) (2025-2032) By Types

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Types

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Types

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 88: Global Heart and Lung Therapy System Market Volume (K) By Region

Table 89: Global Heart and Lung Therapy System Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Application

Table 92: North America Market Volume (K) (2025-2032) By Types

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Types

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Types

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Heart and Lung Therapy System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	4.51 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Terumo; Xenios; Fresenius Medical Care; Maquet; Sorin
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Integration of telehealth platforms with therapy systems to enable remote patient monitoring, creating a hybrid care model that addresses post-pandemic demand for decentralized healthcare solutions.

Challenges2 items

Intense competition among key players is leading to margin compression. Companies must balance innovation with pricing strategies to maintain profitability in a saturated market segment.

Market Segmentation

Loading chart…

Heart and Lung Therapy System Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

VA (Veno-Arterial)

VV (Veno-Venous)

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: Expanding innovation pipeline in ECMO and hybrid heart-lung devices

Terumo: Strengthening OEM tie-ups for component sourcing and cost optimization

Xenios: Prioritizing partnerships with academic medical centers for clinical validation

Fresenius Medical Care: Leveraging local manufacturing to reduce logistics costs in Asia-Pacific

Maquet: Focusing on vertical integration to enhance control over critical system components

Sorin: Investing in premium pricing for high-margin, high-performance therapy systems

Key Heart and Lung Therapy System Companies6 items

Medtronic

Terumo

Xenios

Fresenius Medical Care

Maquet

Sorin

Market Ecosystem

Raw material/component suppliers — provide sensors, biocompatible materials, and electronic parts for device assembly

OEMs / manufacturers — design and produce heart and lung therapy devices, including ventilators and cardiac support systems

Technology providers — develop software platforms for remote monitoring, data analytics, and system interoperability

System integrators — assemble and customize therapy systems for hospital or homecare deployment

Distributors / channel partners — manage logistics, inventory, and regional compliance for end-user access

Service providers / after-sales — offer maintenance, repair, and training for installed therapy systems

End users / buyers — hospitals, clinics, and homecare providers that implement therapy systems for patient treatment

Recent Industry Insights

Analyst Overview

Key Insights4 items

Long-term outlook is optimistic, with a projected CAGR exceeding 6.5% through 2030, fueled by personalized medicine trends.

Innovation landscape is dynamic, emphasizing wearable monitoring devices and regenerative therapies to address unmet clinical needs.

Demand–supply balance shows regional disparities, with developed markets facing equipment shortages during disease outbreaks.

Key risk factors include stringent regulatory compliance, reimbursement challenges, and supply chain vulnerabilities for critical components.

Table of Contents